TPTX
Principal Financial Group’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,506
| Closed | -$640K | – | 2609 |
|
|
2022
Q2 | $640K | Buy |
+8,506
| New | +$640K | ﹤0.01% | 2004 |
|
|
2022
Q1 | – | Sell |
-10,348
| Closed | -$493K | – | 2614 |
|
|
2021
Q4 | $493K | Sell |
10,348
-4,027
| -28% | -$192K | ﹤0.01% | 2125 |
|
|
2021
Q3 | $955K | Sell |
14,375
-2,280
| -14% | -$151K | ﹤0.01% | 2014 |
|
|
2021
Q2 | $1.3M | Sell |
16,655
-577
| -3% | -$45K | ﹤0.01% | 1992 |
|
|
2021
Q1 | $1.63M | Sell |
17,232
-457
| -3% | -$43.2K | ﹤0.01% | 1895 |
|
|
2020
Q4 | $2.16M | Buy |
17,689
+5,107
| +41% | +$622K | ﹤0.01% | 1785 |
|
|
2020
Q3 | $1.1M | Buy |
12,582
+279
| +2% | +$24.4K | ﹤0.01% | 1852 |
|
|
2020
Q2 | $795K | Buy |
12,303
+6,899
| +128% | +$446K | ﹤0.01% | 1873 |
|
|
2020
Q1 | $241K | Buy |
5,404
+173
| +3% | +$7.72K | ﹤0.01% | 2024 |
|
|
2019
Q4 | $326K | Buy |
+5,231
| New | +$326K | ﹤0.01% | 2040 |
|